As of April 16, 2025, Atara Biotherapeutics (ATRA) has a market cap of $35.036 million USD. According to our data, Atara Biotherapeutics is ranked No.8284 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $35.04 M |
-54.30%
|
Dec 31, 2024 | $76.66 M |
3.78%
|
Dec 29, 2023 | $73.87 M |
-84.36%
|
Dec 30, 2022 | $0.47 B |
-79.19%
|
Dec 31, 2021 | $2.27 B |
-19.71%
|
Dec 31, 2020 | $2.83 B |
19.19%
|
Dec 31, 2019 | $2.37 B |
-52.59%
|
Dec 31, 2018 | $5.00 B |
91.93%
|
Dec 29, 2017 | $2.61 B |
27.46%
|
Dec 30, 2016 | $2.04 B |
-46.23%
|
Dec 31, 2015 | $3.80 B |
-1.27%
|
Dec 31, 2014 | $3.85 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
Market Cap | = | ATRA Stock Price | * | ATRA Shares Outstanding |
= | $5.98 | * | 5.86 M | |
= | $35.04 M |